Suchergebnisse - "Green, Angela"

PubPharm (3)

1

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer

enthalten in: Gynecologic oncology | 2023

von Zammarrelli, W. | Ma, W. | Espino, K. | +10

2

Novel therapy in endometrial cancer : How much will we pay?

enthalten in: Gynecologic oncology | 2021

von Green, A. | Makker, V.

CommentOn: Gynecol Oncol. 2021 Aug;162(2):249-255. - PMID 34103196

3

Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer

enthalten in: Gynecologic oncology | 2020

von Aviki, E. | Lavery, J. | Roche, K. | +12

1
[1]